About us
Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here?
Let's talk.
The other half of the equation is
blog posts from readers like you. So if you have an interest in science,
please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our
Privacy Policy and Site Disclaimer.
In a New York courtroom late last month, the chief of the new drugs division of the FDA and a long-time government employee, Steve Galson, reportedly testified in a deposition that he and Janet Woodcock, another long-time federal employee, were cut out of the picture by acting commissioner Lester Crawford when the administration overrode an outside advisory committee and vetoed Plan B, the morning-after birth control pill. Why did Crawford do that? One thing we know about him is that he is under investigation for financial improprieties allegedly involving selling stock in a firm regulated by the FDA while he ran the agency.
Heretofore, the administration's ignoring the science supporting Plan B has been tied to pressure from the religious right. Yet we know Exxon Mobil and its ilk are behind the attack on global warming science. Is there a financial angle to the Plan B as well? That court suit, brought by the liberal Center for Reproductive Rights, merits watching.
Merrill Goozner